Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Colonic wall thickening is related to age and not dose of high strength pancreatin microspheres in children with cystic fibrosis.

Connett GJ, Lucas JS, Atchley JT, Fairhurst JJ, Rolles CJ.

Eur J Gastroenterol Hepatol. 1999 Feb;11(2):181-3.

PMID:
10102230
2.

Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis.

Mac Sweeney EJ, Oades PJ, Buchdahl R, Rosenthal M, Bush A.

Lancet. 1995 Mar 25;345(8952):752-6.

PMID:
7534369
3.

Colonic wall thickness, pancreatic enzyme dose and type of preparation in cystic fibrosis.

Ramsden WH, Moya EF, Littlewood JM.

Arch Dis Child. 1998 Oct;79(4):339-43.

4.
5.

A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis.

Littlewood JM, Connett GJ, Sander-Struckmeier S, Henniges F; Creon 40,000 Study Group.

Expert Opin Drug Saf. 2011 Mar;10(2):197-203. doi: 10.1517/14740338.2011.552499.

PMID:
21342076
6.

A comparison of two pancreatin microsphere preparations in cystic fibrosis.

Elliott RB, Escobar LC, Lees HR, Akroyd RM, Reilly HC.

N Z Med J. 1992 Mar 25;105(930):107-8.

PMID:
1553114
7.

Fibrosing colonopathy in cystic fibrosis: results of a case-control study.

Smyth RL, Ashby D, O'Hea U, Burrows E, Lewis P, van Velzen D, Dodge JA.

Lancet. 1995 Nov 11;346(8985):1247-51.

PMID:
7475715
8.

Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.

Smyth RL, van Velzen D, Smyth AR, Lloyd DA, Heaf DP.

Lancet. 1994 Jan 8;343(8889):85-6.

PMID:
7903780
9.

Colonic toxicity from pancreatins: a contemporary safety issue.

Powell CJ.

Lancet. 1999 Mar 13;353(9156):911-5. Review. No abstract available.

PMID:
10093998
10.

Ultrasound studies of the intestinal wall in patients with cystic fibrosis.

Pohl M, Krackhardt B, Posselt HG, Lembcke B.

J Pediatr Gastroenterol Nutr. 1997 Sep;25(3):317-20.

PMID:
9285384
11.

Colonic changes in cystic fibrosis: clinical-ultrasonographic features and their value for treatment.

Antonelli M, Matrunola M, Tontini A, Diamanti S.

Ital J Gastroenterol Hepatol. 1998 Apr;30(2):232. No abstract available.

PMID:
9675666
12.

Sonographic evaluation of bowel wall thickness in patients with cystic fibrosis.

Dialer I, Hundt C, Bertele-Harms RM, Harms HK.

J Clin Gastroenterol. 2003 Jul;37(1):55-60.

PMID:
12811210
13.
14.

Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls.

Haber HP, Benda N, Fitzke G, Lang A, Langenberg M, Riethmüller J, Stern M.

Gut. 1997 Mar;40(3):406-11.

15.

Colonic strictures in cystic fibrosis.

Taylor CJ.

Lancet. 1994 Mar 12;343(8898):615-6. No abstract available. Erratum in: Lancet 1994 Apr 30;343(8905):1108.

PMID:
7906805
16.

First adult patient with fibrosing colonopathy.

Häusler M, Meilicke R, Biesterfeld S, Heimann G.

Am J Gastroenterol. 1998 Jul;93(7):1171-2.

PMID:
9672356
18.

High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.

FitzSimmons SC, Burkhart GA, Borowitz D, Grand RJ, Hammerstrom T, Durie PR, Lloyd-Still JD, Lowenfels AB.

N Engl J Med. 1997 May 1;336(18):1283-9.

19.

Fibrosing colonopathy in children with cystic fibrosis.

Reichard KW, Vinocur CD, Franco M, Crisci KL, Flick JA, Billmire DF, Schidlow DV, Weintraub WH.

J Pediatr Surg. 1997 Feb;32(2):237-41; discussion 241-2.

PMID:
9044129
20.

Cystic fibrosis with fibrosing colonopathy in the absence of pancreatic enzymes.

Waters BL.

Pediatr Dev Pathol. 1998 Jan-Feb;1(1):74-8.

PMID:
10463274

Supplemental Content

Support Center